Skip to main
NEUP
NEUP logo

NEUP P/E Ratio

P/E Ratio as of Jun 13, 2025: -108.36

Average-103.57
Median-108.08
Minimum-114.15
Maximum-78.15
-108.36
Past Month-33.00 (43.79%)
The P/E ratio for NEUP is -108.36 as of Jun 13, 2025. This represents a decrease of -15.75% compared to its 12-month average P/E ratio of -128.62. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Neuphoria Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Neuphoria Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Neuphoria Therapeutics Inc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NEUP P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$7.01-111.45
May 1, 2025$5.00-79.49
Apr 1, 2025$5.70-90.62
Mar 3, 2025$4.93-78.38
Feb 3, 2025$5.10-81.08
Jan 2, 2025$2.93-563.46

NEUP End of Year P/E Ratio

DateP/E ratioChange
2025-108.36-83.57%
2024-659.62+550.32%
2023-101.43-74.01%
2022-390.21-50.62%
2021-790.14

FAQs About Neuphoria Therapeutics Inc (NEUP) P/E ratio

The latest P/E ratio of NEUP is -108.36, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Neuphoria Therapeutics Inc’s last 12-month average P/E ratio is -128.62, compared to its current P/E ratio of -108.36. This reflects a decrease of -15.75%.

Neuphoria Therapeutics Inc’s current P/E ratio of -108.36 is lower than its last 12-month average P/E of -128.62. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Neuphoria Therapeutics Inc’s average P/E ratio over the last 3 years is -227.61. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Neuphoria Therapeutics Inc’s average P/E ratio over the last 5 years is -220.49. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Neuphoria Therapeutics Inc (NEUP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.